Table 6.
Anticoagulants | Dosages | Advantages | Disadvantages |
---|---|---|---|
Unfractionated heparin | 5–15 IU/kg (initial) 5–10 IU/kg per hour (continuous) |
Ease to use and could be reversed by protamine with a short half-life and lower cost | May induce bleeding, hypertriglyceridemia, HIT, osteoporosis, and hyperkalemia |
Regional heparin with protamine | Heparin prefilter: 1000–1500 U/h Protamine postfilter: 10–12 mg/h |
Lower risk of bleeding | Complexity in administration and high cost |
Enoxaparin | 0.15 mg/kg (initial) 0.05 mg/kg per hour (continuous) |
Lower risk of HIT | Lacking reversal agent, resulting in bioaccumulation risk. Higher cost |
Dabigatran | 15–25 IU/kg (initial) 5 IU/kg per hour (continuous) |
||
Argatroban | 0.1 mg/kg (initial) 0.05–0.2 mg/kg per minute (continuous) |
Can be used in patients with HIT | With a narrow therapeutic window and bleeding and anaphylaxis risk.113 Lacking reversal agent114 |
Bivalirudin | 2 mg/h | ||
RCA | Infused to achieve a citrate blood concentration of 3–4 mmol/L | Lower risk of bleeding and may improve inflammatory profile | Might cause metabolic acidosis because of citrate accumulation. Needing calcium monitoring |
HIT, heparin-induced thrombocytopenia; RCA, regional citrate anticoagulation.